BSX
Basic information
Region (hg38): 11:122977570-122981834
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the BSX gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 13 | 14 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 13 | 1 | 3 |
Variants in BSX
This is a list of pathogenic ClinVar variants found in the BSX region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-122977657-C-G | not specified | Uncertain significance (May 27, 2022) | ||
11-122977658-G-T | Benign (Jun 12, 2018) | |||
11-122977661-C-A | Benign (Jun 14, 2018) | |||
11-122977682-C-T | Likely benign (Jun 01, 2020) | |||
11-122977684-C-G | not specified | Uncertain significance (Aug 22, 2023) | ||
11-122977695-T-C | not specified | Uncertain significance (Sep 15, 2021) | ||
11-122977740-A-G | not specified | Uncertain significance (Nov 22, 2022) | ||
11-122977756-C-T | not specified | Uncertain significance (Oct 22, 2021) | ||
11-122977783-G-A | not specified | Uncertain significance (Jun 22, 2023) | ||
11-122977785-G-C | not specified | Uncertain significance (Mar 23, 2023) | ||
11-122977815-G-A | not specified | Uncertain significance (Sep 30, 2021) | ||
11-122977831-C-T | not specified | Uncertain significance (Oct 05, 2023) | ||
11-122977848-T-G | not specified | Uncertain significance (Nov 08, 2022) | ||
11-122979270-G-A | Benign (Jul 26, 2018) | |||
11-122981502-G-A | not specified | Uncertain significance (Dec 27, 2023) | ||
11-122981502-G-T | not specified | Uncertain significance (Feb 05, 2024) | ||
11-122981551-A-G | not specified | Uncertain significance (Apr 27, 2024) | ||
11-122981640-G-A | not specified | Uncertain significance (Aug 08, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
BSX | protein_coding | protein_coding | ENST00000343035 | 3 | 4151 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00791 | 0.799 | 124613 | 0 | 180 | 124793 | 0.000721 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.484 | 115 | 131 | 0.881 | 0.00000603 | 1466 |
Missense in Polyphen | 23 | 36.511 | 0.62995 | 416 | ||
Synonymous | -0.351 | 62 | 58.6 | 1.06 | 0.00000279 | 500 |
Loss of Function | 1.01 | 4 | 6.85 | 0.584 | 2.99e-7 | 80 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00237 | 0.00188 |
Ashkenazi Jewish | 0.000545 | 0.000497 |
East Asian | 0.000193 | 0.000167 |
Finnish | 0.00123 | 0.00102 |
European (Non-Finnish) | 0.00109 | 0.000883 |
Middle Eastern | 0.000193 | 0.000167 |
South Asian | 0.000131 | 0.000131 |
Other | 0.00248 | 0.00215 |
dbNSFP
Source:
- Function
- FUNCTION: DNA binding protein that function as transcriptional activator. Is essential for normal postnatal growth and nursing. Is an essential factor for neuronal neuropeptide Y and agouti- related peptide function and locomotory behavior in the control of energy balance (By similarity). {ECO:0000250}.;
Intolerance Scores
- loftool
- 0.361
- rvis_EVS
- 0.17
- rvis_percentile_EVS
- 65.56
Haploinsufficiency Scores
- pHI
- 0.190
- hipred
- Y
- hipred_score
- 0.580
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.435
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Bsx
- Phenotype
- normal phenotype; reproductive system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); homeostasis/metabolism phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype;
Zebrafish Information Network
- Gene name
- bsx
- Affected structure
- pinealocyte
- Phenotype tag
- abnormal
- Phenotype quality
- decreased occurrence
Gene ontology
- Biological process
- regulation of transcription by RNA polymerase II;locomotory behavior;eating behavior;positive regulation of transcription by RNA polymerase II;mammary gland involution
- Cellular component
- nucleus;transcription factor complex
- Molecular function
- RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription factor activity;sequence-specific DNA binding